Dette er påvist ved terapeutiske doser i kontrollerede, mellemlange eller langvarige kliniske undersøgelser: metformin reducerer total- kolesterol, LDLc og triglyceridniveauer.
This has been shown at therapeutic doses in controlled, medium-term or long-term clinical studies: metformin reduces total cholesterol, LDLc and triglyceride levels.